Jan 16 2020
Merck Pharmaceuticals is Seeking Participants for a Study

Posted at Jan 16 2020
h in News by Monica Gow

Merck Pharmaceuticals is seeking participants for a study that involves discontinuation of treatment for excessive daytime sleepiness. This important study is in preparation for clinical trials in the development of a new treatment for EDS.

Participants should have a diagnosis of Type 1 Narcolepsy, be over the age of 18 and be willing to travel to designated sites in the USA.

Reimbursement for travel and accommodation costs are provided. If you are interested in the study, please contact the location center closest to you listed in the image below

Print page

Jan 16 2020 Merck Pharmaceuticals is Seeking Participants for a Study

2 events, 1

2 events, 1

2 events, 2

2 events, 2

2 events, 3

2 events, 3

1 event, 4

1 event, 4

1 event, 5

1 event, 5

2 events, 6

2 events, 6

0 events, 7

0 events, 7

2 events, 8

2 events, 8

2 events, 9

2 events, 9

2 events, 10

2 events, 10

1 event, 11

1 event, 11

1 event, 12

1 event, 12

1 event, 13

1 event, 13

0 events, 14

0 events, 14

2 events, 15

2 events, 15

2 events, 16

2 events, 16

2 events, 17

2 events, 17

1 event, 18

1 event, 18

1 event, 19

1 event, 19

1 event, 20

1 event, 20

0 events, 21

0 events, 21

2 events, 22

2 events, 22

2 events, 23

2 events, 23

3 events, 24

3 events, 24

1 event, 25

1 event, 25

1 event, 26

1 event, 26

2 events, 27

2 events, 27

Wake Up Narcolepsy 2024 National Summit

Wake Up Narcolepsy 2024 National Summit

Jan 16 2020
Merck Pharmaceuticals is Seeking Participants for a Study